THBS2 and hepatocellular carcinoma: As shown in Table 4, the TSP2 High + FIB‐4 High group at SVR12 displayed a sensitivity of 0.375, specificity of 0.941, positive predictive value (PPV) of 0.462, and negative predictive value of 0.917 for predicting HCC occurrence after DAA therapy.